• Explore /
  • Poster
  • / Phase I study of ADI-PEG 20 in combination with pemetrexed and cisplatin (TRAP) in patients with ASS1-deficient mesothelioma and non-squamous lung cancer.

Phase I study of ADI-PEG 20 in combination with pemetrexed and cisplatin (TRAP) in patients with ASS1-deficient mesothelioma and non-squamous lung cancer.

Abstract Poster

Authors

null

Peter Wojciech Szlosarek

St Bartholomew's Hospital, London, United Kingdom

Peter Wojciech Szlosarek , James F. Spicer , Teresa Szyszko , Gary J. R. Cook , Pui Ying Chan , Mirela Hategan , Dimitra Repana , Jeremy Peter Steele , Peter Schmid , Monica Diaz , Amanda Johnston , Michael Sheaff , Ramsay Khadeir , John S. Bomalaski , Simon Pacey

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Cytotoxic and Other Novel Agents

Clinical Trial Registration Number

NCT02029690

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS2612)

DOI

10.1200/jco.2015.33.15_suppl.tps2612

Abstract #

TPS2612

Poster Bd #

322b

Abstract Disclosures

Similar Posters

First Author: Melissa Phillips

First Author: Peter Wojciech Szlosarek

First Author: Akhila Ganeshi Wimalasingham

First Author: Pui Ying Chan